Structure-guided optimization of N-(5-((2-oxopropyl) thio)-1,3,4-thiadiazol-2-yl) propionamide frameworks as potent SARS-CoV-2 Mpro inhibitor for treating coronavirus disease.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42314596

Ammena Y Binsaleh; Asma Sardar; Faisal Asif; Hayam A Alwabsi; Hina Sarfraz; Maher S Alwethaynani; Mariam Mojally; Nawal Al-Hoshani; Rafaqat Hussain; Rania Ali El Hadi Mohamed; Reem Nabil Hassan; Yousaf Khan

Jun 19, 2026